News

Filter

Current filters:

Thalomid

1 to 9 of 111 results

First-line multiple myeloma patient share in Europe is variable by country

29-08-2012

Despite the considerable heterogeneity across different European countries, surveyed hematologist-oncologists…

AlkeranBiotechnologyCelgeneGlaxoSmithKlineHealthcareJohnson & JohnsonMarkets & MarketingOncologyPharmaceuticalThalomidVelcade

Celgene falls up to 17% on low 1st-qtr forecast

03-04-2009

Shares in Celgene fell up to 17% on April 1, after the US drugmaker reported preliminary first-quarter…

Amino AcidsAzacitidineInjectionlenalidomidePhysostigmine SalicylateRevlimidThalidomideThalomidVidaza

Zolinza/Velcade combo enters Ph IIb MM trial

26-01-2009

The Multiple Myeloma Research Consortium has initiated a Phase IIb study of Merck & Co's Zolinza (vorinostat),…

bortezomiblenalidomideMerck KGaANystatinOralRevlimidThalidomideThalomidVelcadevorinostatZolinza

Celgene's Revlimid linked to 14 cases of serious skin reactions, says FDA report

29-09-2008

A US Food and Drug Administration postmarket safety review of Celgene's Revlimid (lenalidomide) identified…

lenalidomideRevlimidThalidomideThalomid

1 to 9 of 111 results

COMPANY SPOTLIGHT

Menarini

Back to top